SP
Starpharma Holdings Limited
SPHRY · OTC
$5.46 +4.50% (+$0.24)
1M +8.66%
Market Cap $326.4M
P/E Ratio -
Div. Yield 1.23%
ROE 37.73%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 23.69x
P/S 27.69x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 26.58%
Rev. growth 39.49%
FCF growth N/A
Profitability
20 /100
Weak Net margin 61.95%
Op. margin 159.60%
FCF margin 29.67%
Quality
8 /100
Poor ROE 37.73%
ROA 38.39%
Asset turnover 0.62x
Debt
100 /100
Low Current ratio 3.40x
Debt/Equity 0.05x
Net debt/EBITDA N/A
Stability
43 /100
Moderate Rev. volatility 72.71%
EPS volatility 34.85%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SPHRY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheryl Maley
Employees
50
Headquarters
Abbotsford
Evenimente viitoare
02 MAR.
Earnings
Upcoming earnings report